US Edition
Genomics Paving Way For Equity In Cancer Care In Africa And Beyond
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Genomics Paving Way For Equity In Cancer Care In Africa And Beyond
NovaSeq X Plus Yemaachi Biotech, a pioneering genomics research company based in Ghana and Illumina, a global leader in sequencing technology, has announced the arrival of the NovaSeq X Plus (the most powerful sequencer manufactured by Illumina yet), to Ghana. It is the first of its kind in the country, aimed at accelerating research that promises to reduce inequities in cancer care in African population. Cancer diagnosis and treatment globally …
Genomics paving the way for equity in cancer care in Africa and around the world
Yemaachi Biotech, a pioneering genomics research company based in Ghana and Illumina , a global leader in sequencing technology, announced the arrival of the NovaSeq X Plus (the most powerful sequencer manufactured by Illumina yet), to Ghana. It is the first of its kind in the country, aimed at accelerating research that promises to reduce inequities in cancer care in African population. Cancer diagnosis and treatment globally is rapidly evolvi…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
